Changes in fibrinopeptide A peptides in the sera of rats chronically exposed to low doses of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)

Environmental Toxicology and Pharmacology - Tập 33 - Trang 191-196 - 2012
Xi Chen1, Shi-wei Ma2, Xiao-ming Ma3, Yuan-jing Xu1, Nai-jun Tang1
1Department of Occupational Health, School of Public Health, Tianjin Medical University, Qixiangtai Road No. 22, Heping District, Tianjin 300070, China
2China Academy of Railway Sciences, Daliushu Road No. 2, Haidian District, Beijing 100036, China
3Qing Hai Center for Diseases Prevention and Control, Bayi Road No. 66, Xining, Qinghai 810007, China

Tài liệu tham khảo

An, 2010, Peptides in low molecular weight fraction of serum associated with hepatocellular carcinoma, Dis. Markers, 29, 11, 10.1155/2010/681876 Chen, 2009, Proteomic analysis of the rat ovary following chronic low-dose exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), J. Toxicol. Environ. Health A, 72, 717, 10.1080/15287390902841136 Conrad, 2008, Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening, J. Gen. Intern. Med., 23, 78, 10.1007/s11606-007-0411-1 Dear, 2007, Acquired dysfibrinogenemia caused by monoclonal production of immunoglobulin lambda light chain, Haematologica, 92, e111, 10.3324/haematol.11837 Doolittle, 1979, The amino acid sequence of the alpha-chain of human fibrinogen, Nature, 280, 464, 10.1038/280464a0 Ebert, 2006, Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry, J. Proteome Res., 5, 2152, 10.1021/pr060011c Freed, 2008, Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples, Laryngoscope, 118, 61, 10.1097/MLG.0b013e31814cf389 French, 2000, Pathogenesis of experimental alcoholic liver disease in the rat, Methods Achiev. Exp. Pathol., 13, 181 Gupta, 1973, Pathologic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals, Environ. Health Perspect., 5, 125, 10.1289/ehp.7305125 Guzzetta, 2005, An evaluation of the effects of a standard heparin dose on thrombin inhibition during cardiopulmonary bypass in neonates, Anesth. Analg., 100, 1276, 10.1213/01.ANE.0000149590.59294.3A Hartwig, 1991, Studies on the assembly and secretion of fibrinogen, J. Biol. Chem., 266, 6578, 10.1016/S0021-9258(18)38156-0 Henshel, 1997, Brain asymmetry as a potential biomarker for developmental TCDD intoxication: a dose–response study, Environ. Health Perspect., 105, 718, 10.1289/ehp.97105718 Hirsh, 1981, Blood tests for the diagnosis of venous and arterial thrombosis, Blood, 57, 1, 10.1182/blood.V57.1.1.1 Joo, 2003, Monitoring protein expression by proteomics: human plasma exposed to benzene, Proteomics, 3, 2402, 10.1002/pmic.200300616 Kang, 2006, Health status of Army Chemical Corps Vietnam veterans who sprayed defoliant in Vietnam, Am. J. Ind. Med., 49, 875, 10.1002/ajim.20385 Kim, 2003, Impact of Agent Orange exposure among Korean Vietnam veterans, Ind. Health, 41, 149, 10.2486/indhealth.41.149 Kociba, 1976, 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD): results of a 13-week oral toxicity study in rats, Toxicol. Appl. Pharmacol., 35, 553, 10.1016/0041-008X(76)90078-8 Kociba, 1978, Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats, Toxicol. Appl. Pharmacol., 46, 279, 10.1016/0041-008X(78)90075-3 Landi, 2005, CYP1A1 and CYP1B1 genotypes, haplotypes, and TCDD-induced gene expression in subjects from Seveso, Italy, Toxicology, 207, 191, 10.1016/j.tox.2004.08.021 McConnell, 1978, Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rhesus monkeys (Macaca mulatta) following a single oral dose, Toxicol. Appl. Pharmacol., 43, 175, 10.1016/S0041-008X(78)80042-8 Michalek, 2001, Serum dioxin and peripheral neuropathy in veterans of operation ranch hand, Neurotoxicology, 22, 479, 10.1016/S0161-813X(01)00052-3 Mustafa, 2008, An enhanced postnatal autoimmune profile in 24 week-old C57BL/6 mice developmentally exposed to TCDD, Toxicol. Appl. Pharmacol., 10.1016/j.taap.2008.04.015 Nossel, 1971, Radioimmunoassay of human fibrinopeptide A, Proc. Natl. Acad. Sci. U.S.A., 68, 2350, 10.1073/pnas.68.10.2350 Orvisky, 2006, Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma, Proteomics, 6, 2895, 10.1002/pmic.200500443 Pelclova, 2006, Adverse health effects in humans exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), Rev. Environ. Health, 21, 119, 10.1515/REVEH.2006.21.2.119 Petricoin, 2002, Use of proteomic patterns in serum to identify ovarian cancer, Lancet, 359, 572, 10.1016/S0140-6736(02)07746-2 Schnabel, 2008, Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection, Hypertension, 51, 1651, 10.1161/HYPERTENSIONAHA.107.105668 Shevchenko, 2001, Charting the proteomes of organisms with unsequenced genomes by MALDI-quadrupole time-of-flight mass spectrometry and BLAST homology searching, Anal. Chem., 73, 1917, 10.1021/ac0013709 Sista, 2008, Heterogeneous immunoassays using magnetic beads on a digital microfluidic platform, Lab Chip, 8, 2188, 10.1039/b807855f Sugiyama, 2009, PEGylated lactoferrin enhanced its hepatoprotective effects on acute liver injury induced by carbon tetrachloride in rats, Food Chem. Toxicol., 47, 1453, 10.1016/j.fct.2009.03.030 Sun, 2008, Association of fibrinogen and fibrinogen gene beta148 and beta854 polymorphisms with coronary heart disease, Cardiology, 111, 167, 10.1159/000121599 Villanueva, 2004, Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry, Anal. Chem., 76, 1560, 10.1021/ac0352171 Weerasinghe, 2011, Fibrinogen-γ proteolysis and solubility dynamics during apoptotic mouse liver injury: heparin prevents and treats liver damage, Hepatology, 53, 1323, 10.1002/hep.24203 Zhu, 2009, Abnormal expression of fibrinogen gamma (FGG) and plasma level of fibrinogen in patients with hepatocellular carcinoma, Anticancer Res., 29, 2531 Zinkl, 1973, Hematologic and clinical chemistry effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals, Environ. Health Perspect., 5, 111, 10.1289/ehp.7305111